Search Within

David B Page

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (4)
  2. Hematologic Malignancies, Division of (4)
  3. Solid Tumor Oncology Division (4)
  4. Gastrointestinal Oncology Service (3)
  5. Melanoma and Immunotherapeutics Service (3)
  6. Center for Hematologic Malignancies (2)

More Groups

People
  1. Geoffrey Ku (2)
  2. James Allison (2)
  3. Jedd Wolchok (2)
  4. Jianda Yuan (2)
  5. Samuel Funt (2)
  6. Achim Jungbluth (1)

More People

Years
  1. 2015 (2)
  2. 2010 (2)
Publications
  1. Blood (1)
  2. Cancer (1)
  3. Cancer Immunity (1)
  4. Journal for ImmunoTherapy of Cancer (1)
Publishers
  1. Academy of Cancer Immunology (1)
  2. American Society of Hematology (1)
  3. Biomed Central Ltd (1)
  4. Wiley Blackwell (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The long PD-1 receptor binding kinetics of nivolumab may increase efficacy of subsequent therapy in relapsed and refractory multiple myeloma patients
    Meeting Abstract

    Funt, S. A.; Page, D. B.; Cattry, D.; Lendvai, N.; Hassoun, H.; Landgren, O.; Borrello, I. M.; Lesokhin, A. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Tumor immunology and cancer immunotherapy: Summary of the 2014 SITC primer
    Journal Article

    Page, D. B.; Bourla, A. B.; Daniyan, A.; Naidoo, J.; Smith, E.; Smith, M.; Friedman, C.; Khalil, D. N.; Funt, S.; Shoushtari, A. N.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save
  • Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy
    Journal Article

    Yuan, J.; Page, D. B.; Ku, G. Y.; Li, Y.; Mu, Z.; Ariyan, C.; Gallardo, H. F.; Roman, R. A.; Heine, A. I.; Terzulli, S. L.; more...
    Cancer Immunity (2010)

    Fulltext@MSK | Save
  • Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting lymphocyte count after 2 doses correlates with survival
    Journal Article

    Ku, G. Y.; Yuan, J.; Page, D. B.; Schroeder, S. E. A.; Panageas, K. S.; Carvajal, R. D.; Chapman, P. B.; Schwartz, G. K.; Allison, J. P.; Wolchok, J. D.
    Cancer (2010)

    Fulltext@MSK | Save